Karapolat Sami, Turkyilmaz Atila, Tekinbas Celal
Department of Thoracic Surgery, Karadeniz Technical University Medical School , Trabzon, Turkey .
J Laparoendosc Adv Surg Tech A. 2018 Jun;28(6):726-729. doi: 10.1089/lap.2017.0634. Epub 2018 Jan 12.
Raynaud's disease is a disorder that is characterized by attacks of pain, cyanosis, redness, and numbness in the upper extremities caused by vasospasm of digital arteries due to cold or emotional stress. We aimed at demonstrating our experiences with endoscopic thoracic sympathectomy (ETS) in the treatment of Raynaud's disease.
From 48 patients who underwent ETS for various reasons at our department between January 2014 and January 2015, we reviewed 9 patients with Raynaud's disease (18.7%) with respect to their demographic characteristics such as gender and age, postoperative complications, short-term results, side effects, recurrence of symptoms, and long-terms results.
The symptoms and findings reappeared and the number and dosage of the drugs used returned to their preoperative levels in 66.6% of the patients at month 6, and in all patients except 1 at the end of the 1st year.
ETS should be considered an ultimate choice for patients with Raynaud's disease who have treatment-resistant severe symptoms and serious complications, disturbed social and daily lives, and impaired quality of life, and all patients should be properly informed before the surgery about the possibility of a high rate of recurrence.
雷诺氏病是一种以因寒冷或情绪应激导致指动脉血管痉挛，引起上肢疼痛、发绀、发红和麻木发作为特征的疾病。我们旨在展示我们在内镜下胸交感神经切除术（ETS）治疗雷诺氏病方面的经验。
在2014年1月至2015年1月期间，我们科室有48例患者因各种原因接受了ETS，我们回顾了9例（18.7%）患有雷诺氏病的患者，涉及他们的人口统计学特征，如性别和年龄、术后并发症、短期结果、副作用、症状复发情况以及长期结果。
66.6%的患者在术后6个月时症状和体征再次出现，所用药物的数量和剂量恢复到术前水平，在第1年末，除1例患者外，所有患者均如此。
对于患有治疗抵抗性严重症状和严重并发症、社会和日常生活受到干扰且生活质量受损的雷诺氏病患者，ETS应被视为最终选择，并且在手术前应向所有患者充分告知高复发率可能性。
